CAS ID: | 41859-67-0 |
Molecular Formula: | C19H20ClNO4 |
Molecular Weight: | 361.8 g/mol |
Monoisotopic Mass: | 361.1081 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | BEZALIP | BEZAGEN XL | LIPAROL XL | BM 15.075 | BEZALIP-MONO | FIBRAZATE XL | BEZAFIBRATE | ZIMBACOL XL |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 18513333 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
Process I | attenue inflammation | ||
Process II | HSCs activation | ||
Process III | prevenet collagen deposition | ||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT02937012 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Recruiting |
First Received | October 18, 2016 | Last Verified | April 23, 2018 |
Sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
PubChem: | 39042 |
ChEMBL: | CHEMBL264374 |